Shang Hai Zheng Quan Bao·2026-02-23 15:07Group 1: Company Performance - Dayun Co., Ltd. reported a net profit of 84.21 million yuan for the year 2025, representing a year-on-year increase of 31.87% [8] - The total operating revenue for Dayun Co., Ltd. in 2025 was 468 million yuan, reflecting a growth of 15.7% compared to the previous year [8] Group 2: Major Events - Lixun Precision announced its first share buyback of 9.9006 million shares, costing nearly 500 million yuan [14] - ST Jinglan indicated that it may apply for a trading suspension if its stock price continues to rise abnormally, having increased by 86.90% from January 23 to February 13, 2026 [3][4] - Guotou Capital expects a negative impact on its 2026 net profit due to valuation adjustments of its silver futures investment fund, estimated to be less than 5% of its audited net profit for 2024 [5] Group 3: Corporate Actions - New Qianglian and Tongfu Microelectronics have had their applications for issuing shares to specific investors accepted by the Shenzhen Stock Exchange [10] - Reliable Co., Ltd. announced the removal of its independent director, Jing Naiquan, due to loss of independence and failure to fulfill duties [6] - Frontline Bio signed an exclusive licensing agreement with GlaxoSmithKline for two small RNA products, receiving an upfront payment of 40 million USD [12] Group 4: Project Wins - The company Jiayou International has officially commenced commercial operations on the Zambia Ndola to Sakanya highway, marking a significant milestone in its PPP project [15] - Donghong Co., Ltd. won a procurement project for pressure steel pipes and accessories worth 353 million yuan [14] - Shuangliang Energy's subsidiary won a project in the Middle East with an estimated value of 100.26 million yuan [16]